Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16207291
Conclusion of this study
No severe adverse events were reported. The substantial reduction in risk of death, low adverse events reported and low costs related to this intervention suggest great potential for melatonin in treating cancer. Confirming the efficacy and safety of melatonin in cancer treatment will require completion of blinded, independently conducted RCTs.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
